IP Library Patent Application 11739906
Patent Application
App. No. 11/739,906

Method For Detecting at Least One Designated Genetic Sequence

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/739,906
Abstract

The present invention provides a method to rapidly provide genotype screening of a plurality of biological samples in a designated well of a microwell container for remote user by a screening laboratory. The screening method can be used to determine if a biological sample is heterozygous, homozygous or wild for a designated genetic sequence.

Claims (30)

1 . A method for detecting at least one designated genetic sequence in a biological sample comprising:

a) treating said biological sample to obtain a lysate containing cellular debris including a genomic nucleic acid, wherein genomic said nucleic acid includes at least a portion of an intact nucleic acid;

b) separating a standard concentration of genomic nucleic acid using magnetic particles; and

c) screening said standard concentration of genomic nucleic acid to detect said designated genetic sequence.

2 . The method of claim 1 , wherein the step of separating a standard concentration of genomic nucleic acid includes the step of treating said lysate to saturate said magnetic particles with genomic nucleic acid.

3 . The method of claim 2 wherein the step of separating a standard concentration of genomic nucleic acid includes the step of:

(a) separating said genomic nucleic acid from said cellular debris using magnetic particles, and

(b) adding an elution solution to disassociate a standard concentration of genomic nucleic acid from said magnetic particles.

4 . The method of claim 2 wherein the step of treating said lysate to saturate said magnetic particles includes adding a sufficient amount of chaotropic salt to bind said genomic nucleic acid to said magnetic particles.

5 . The method of claim 1 further comprising the step of processing said genomic nucleic acid to be single stranded.

6 . The method of claim 2 wherein the elution solution is nuclease free water.

7 . The method of claim 1 wherein said biological sample is tissue biopsy.

8 . The method of claim 1 wherein said biological sample is fecal matter.

9 . The method of claim 1 wherein said biological sample is embryonic tissue.

10 . The method of claim 1 wherein said biological sample is bone marrow.

11 . The method of claim 1 wherein said biological sample is embryonic stem cells.

12 . The method of claim 1 wherein said biological sample is from a human.

13 . The method of claim 1 wherein the step of treating said biological sample to obtain a lysate includes treating said biological sample with a sufficient amount of lysis reagent.

14 . The method of claim 1 wherein the step of treating said biological sample to obtain a lysate includes treating said biological sample with a sufficient amount of proteinase K.

15 . The method of claim 1 wherein said biological sample contains a virus.

16 . The method of claim 1 wherein said standard concentration of said genomic nucleic acid is about 0.2 O.D. units in a 50 μl path length.

17 . A method for detecting at least one designated genetic sequence in a biological sample comprising:

a) treating said biological sample to obtain a lysate containing cellular debris including a genomic nucleic acid, wherein said genomic nucleic acid includes at least a portion of intact nucleic acid;

b) separating said genomic nucleic acid using magnetic particles;

c) adding at least one probe and primer set corresponding to one of said at least one designated genetic sequence to said biological sample in said at least one well of a microwell container;

d) adding at least one probe and primer set corresponding to a reference sequence to said biological sample in said at least one well of a microwell container;

e) screening said biological sample in said at least one well of a microwell container to obtain screening results, wherein one of said screening results is probe values; and

f) comparing the probe values for said probe corresponding to said designated genetic sequence with said probe value corresponding to said reference sequence to detect said at least one designated genetic sequence.

18 . The method of claim 17 wherein said biological sample is blood.

19 . The method of claim 17 wherein the probe corresponding to said reference sequence probe is SEQ ID NO. 21.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: LANDMARK COMMUNITY BANK
To: TRANSNETYX, INC.
Reel/Frame 045496/0474 →
RELEASE OF SECURITY INTEREST Recorded Apr 10, 2018
From: PENINSULA FUND V LIMITED PARTNERSHIP
To: TRANSNETYX, INC.
Reel/Frame 045496/0775 →
SECURITY INTEREST Recorded Apr 30, 2015
From: TRANSNETYX, INC.
To: THE PENINSULA FUND V LIMITED PARTNERSHIP
Reel/Frame 035539/0054 →
SECURITY INTEREST Recorded May 29, 2014
From: TRANSNETYX
To: LANDMARK COMMUNITY BANK
Reel/Frame 033053/0834 →
RECORDING OF ASSIGNMENT OF APPLICATION NO. 11/166,990 AGAINST DIVISIONAL APPLICATIONS OF APPLICATION NO. 11/166,990 Recorded Jul 10, 2007
From: HODGE, TIMOTHY A.
To: TRANSNETYX, INC.
Reel/Frame 019535/0778 →